Related Experiment Video

Updated: Jul 24, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.3K

The international Unity study for antivirals against mpox is a blueprint for future epidemics

Erica Telford1, Beatriz Grinsztejn2, Inge Christoffer Olsen3

  • 1ANRS|Emerging Infectious Diseases/Inserm, Paris, France.

Nature Medicine
|June 30, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Related Experiment Videos

Last Updated: Jul 24, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.3K
Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

55
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
55
Subviral Agents01:29

Subviral Agents

45
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
45

Articles linked to this work by shared authors, journal, and citation graph.

Community-Associated Methicillin-Resistant Staphylococcus aureus Among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV Who Engage in Chemsex in Barcelona, Spain: Epidemiological Patterns and Implications for Infection Control.

Microorganisms·2026

Lenacapavir Use in France: A National, Observational Study (LENAddOn).

Open forum infectious diseases·2026

Sustained Virologic Suppression After Discontinuation of Long-acting Cabotegravir/Rilpivirine: A Two-case Series Highlighting Unexpected Heterogeneity in Pharmacokinetics and Viral Control.

Open forum infectious diseases·2026

Pretreatment Resistance to Integrase Inhibitors in the Swiss HIV Cohort Study From 1995 to 2025.

Open forum infectious diseases·2026

Epidemiology and Clinical Impact of Clonal Hematopoiesis in People with HIV.

The Journal of infectious diseases·2026

Outcomes for persons with triple-class resistant HIV and a history of virologic failure.

International journal of antimicrobial agents·2026

Isthmin-2 is a first-trimester predictor of preeclampsia and fetal growth restriction.

Nature medicine·2026

Antifungal therapy improves microbiome dynamics in inflammatory bowel disease.

Nature medicine·2026

Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

Nature medicine·2026

Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.

Nature medicine·2026

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Nature medicine·2026

Induced pluripotent stem cells from discovery to translation.

Nature medicine·2026

First draft genome sequence of the emerging sexually transmitted dermatophyte Trichophyton mentagrophytes genotype VII.

Medical mycology·2026

Tradeoffs between targeted and expanded testing strategies for influenza A(H5N1).

ASM case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us